Taiho Pharmaceutical Co., Ltd.,
Overview
Taiho Pharmaceutical Co., Ltd., is a pharmaceutical company based in Japan, founded in 1963, with 1,001-5,000 employees.
Active pharmaceutical ingredients supplied
Substances Taiho Pharmaceutical Co., Ltd., is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Taiho Pharmaceutical Co., Ltd., holds 2 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- TRIFLURIDINE DRUG SUBSTANCEActive2020-03-16
- TIPIRACIL HYDROCHLORIDE (TPI)Active2014-11-25
- TAC-101 DRUG SUBSTANCEInactive2008-02-06
- WM-1-DAITO INTERMEDIATE FOR CDHPInactive2007-06-27
- IPD-1151T DRUG SUBSTANCEInactive2004-04-12
- GTS-21Inactive1999-12-28
- CDHPInactive1997-06-18
- TAS-103Inactive1996-05-31
- UFT CAPSULES (TEGAFUR AND URACIL)Inactive1993-06-17
- TEGAFURInactive1993-06-17
- FTORAFUR (ALSO CALLED FUTRAFUL OR TEGAFUR)Inactive1981-08-05
FDA compliance signals
2 FDA enforcement records linked to this company.
- 4832024-01-26
Scientifically sound laboratory controls
- 4832024-01-26
Calibration/Inspection/Checking not done
Is this Taiho Pharmaceutical Co., Ltd.,? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.